Modular Biopharmaceutical Manufacturing Facilities Market

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

1. 2.1. Market Overview

2. 2.2. Market Definition

3. 2.3. Scope of the Study

4. 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

1. 3.1. Market Drivers

2. 3.2. Market Restraints

3. 3.3. Market Opportunities

4. 3.4. Porter’s Five Forces Analysis

5. 3.5. Industry Value Chain Analysis

6. 3.6. Policies and Regulations

7. 3.7. Strategic Recommendations

8. 3.8. Product Pipeline Analysis

9. 3.9. Incidence and Prevalence Analysis

10. 3.10. Patent Analysis

4. TECHNOLOGICAL OUTLOOK

5. MODULAR BIOPHARMACEUTICAL MANUFACTURING FACILITIES MARKET BY FACILITY TYPE

1. 5.1. Introduction

2. 5.2. Single-Use Modular Facilities

3. 5.3. Hybrid Modular Facilities

4. 5.4. Fully Stainless-Steel Modular Facilities

6. MODULAR BIOPHARMACEUTICAL MANUFACTURING FACILITIES MARKET BY TECHNOLOGY

1. 6.1. Introduction

2. 6.2. Prefabricated Cleanrooms

3. 6.3. Plug-and-Play POD Systems

4. 6.4. Process Skids & Modules

5. 6.5. Utility & Support Modules

6. 6.6. Automation & Control Systems

7. MODULAR BIOPHARMACEUTICAL MANUFACTURING FACILITIES MARKET BY END-USER

1. 7.1. Introduction

2. 7.2. Pharmaceutical Companies

3. 7.3. Biotechnology Firms

4. 7.4. Contract Development and Manufacturing Organizations (CDMOs)

5. 7.5. Research & Academic Institutions

6. 7.6. Government & Public Health Agencies

8. MODULAR BIOPHARMACEUTICAL MANUFACTURING FACILITIES MARKET BY GEOGRAPHY

1. 8.1. Introduction

2. 8.2. North America

   1. 8.2.1. USA

   2. 8.2.2. Canada

   3. 8.2.3. Mexico

3. 8.3. South America

   1. 8.3.1. Brazil

   2. 8.3.2. Argentina

   3. 8.3.3. Others

4. 8.4. Europe

   1. 8.4.1. United Kingdom

   2. 8.4.2. Germany

   3. 8.4.3. France

   4. 8.4.4. Spain

   5. 8.4.5. Others

5. 8.5. Middle East and Africa

   1. 8.5.1. Saudi Arabia

   2. 8.5.2. UAE

   3. 8.5.3. Others

6. 8.6. Asia Pacific

   1. 8.6.1. China

   2. 8.6.2. India

   3. 8.6.3. Japan

   4. 8.6.4. South Korea

   5. 8.6.5. Indonesia

   6. 8.6.6. Thailand

   7. 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

1. 9.1. Major Players and Strategy Analysis

2. 9.2. Market Share Analysis

3. 9.3. Mergers, Acquisitions, Agreements, and Collaborations

4. 9.4. Competitive Dashboard

10. COMPANY PROFILES

1. 10.1. G-CON Manufacturing

2. 10.2. Pharmadule Morimatsu

3. 10.3. Germfree

4. 10.4. NNE

5. 10.5. Exyte

6. 10.6. IPS (Integrated Project Services)

7. 10.7. AGC Modular

8. 10.8. Byrne Modular

9. 10.9. Capital Projects & Infrastructure

10. 10.10. Holston Modular

11. APPENDIX

1. 11.1. Currency

2. 11.2. Assumptions

3. 11.3. Base and Forecast Years Timeline

4. 11.4. Key benefits for the stakeholders

5. 11.5. Research Methodology

6. 11.6. Abbreviations